Lancet
The most recent articles from:
Lancet
-
Randomized Controlled Trial Multicenter Study Comparative Study
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Previous evidence supports androgen deprivation therapy (ADT) with primary radiotherapy as initial treatment for intermediate-risk and high-risk localised prostate cancer. However, the use and optimal duration of ADT with postoperative radiotherapy after radical prostatectomy remains uncertain. ⋯ Cancer Research UK, UK Research and Innovation (formerly Medical Research Council), and Canadian Cancer Society.